- Home
- LTRY vs CHRO Comparison
LTRY vs CHRO Comparison
Compare LTRY & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- CHRO
- Stock Information
- Founded
- LTRY 2015
- CHRO 2002
- Country
- LTRY United States
- CHRO United States
- Employees
- LTRY N/A
- CHRO N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- CHRO
- Sector
- LTRY Technology
- CHRO
- Exchange
- LTRY Nasdaq
- CHRO Nasdaq
- Market Cap
- LTRY 3.2M
- CHRO 3.8M
- IPO Year
- LTRY N/A
- CHRO 2024
- Fundamental
- Price
- LTRY $0.37
- CHRO $1.90
- Analyst Decision
- LTRY
- CHRO Strong Buy
- Analyst Count
- LTRY 0
- CHRO 1
- Target Price
- LTRY N/A
- CHRO N/A
- AVG Volume (30 Days)
- LTRY 1.1M
- CHRO 855.2K
- Earning Date
- LTRY 12-16-2024
- CHRO 02-20-2025
- Dividend Yield
- LTRY N/A
- CHRO N/A
- EPS Growth
- LTRY N/A
- CHRO N/A
- EPS
- LTRY N/A
- CHRO N/A
- Revenue
- LTRY $6,143,350.00
- CHRO N/A
- Revenue This Year
- LTRY N/A
- CHRO N/A
- Revenue Next Year
- LTRY N/A
- CHRO N/A
- P/E Ratio
- LTRY N/A
- CHRO N/A
- Revenue Growth
- LTRY 190.77
- CHRO N/A
- 52 Week Low
- LTRY $0.22
- CHRO $0.45
- 52 Week High
- LTRY $3.56
- CHRO $6.00
- Technical
- Relative Strength Index (RSI)
- LTRY 43.59
- CHRO 86.63
- Support Level
- LTRY $0.36
- CHRO $0.81
- Resistance Level
- LTRY $0.40
- CHRO $1.10
- Average True Range (ATR)
- LTRY 0.06
- CHRO 0.26
- MACD
- LTRY -0.02
- CHRO 0.08
- Stochastic Oscillator
- LTRY 2.73
- CHRO 70.64
About LTRY Lottery.com Inc.
Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.